OutSee
To add a bio or update company history, please click update information.
News from OutSee
OutSee
24 Jun 2025
OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery
OutSee builds a predictive genomics platform that uses hypothesis-free AI modelling to discover new therapeutic targets, supporting precision medicine across neurological, rare and metabolic diseases.
OutSee
12 Jan 2026
OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
OutSee develops AI-driven genomics software that identifies disease targets directly from genetic data, supporting drug discovery by uncovering biological mechanisms missed by conventional analysis methods.
OutSee
- Life Sciences
- Cambridge, United Kingdom
- £4.3m
- outsee.co.uk
- Update Information
More venture news
- 9 Mar 2026
BIOCAPTIVABIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy
EquityLife Sciences - 4 Mar 2026
LifeCellsNILifeCellsNI secures £590k in pre-seed funding led by The AMP Angel Syndicate for regulated stem cell storage and biobanking facility
Pre-seedLife Sciences - 3 Mar 2026
Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
Series ALife Sciences
